– Reuters
Barclays Maintains Overweight on Hess, Raises Price Target to $155
Barclays analyst Jeanine Wai maintains Hess (NYSE:HES) with a Overweight and raises the price target from $145 to $155.
President Biden Says He’s Ready To Work With House Speaker McCarthy
– Reuters
Related Posts
Why BlackBerry (BB) Stock Is Moving
BlackBerry Ltd (NYSE: LTD) shares are trading lower by 3.15% to $5.06 Monday morning, pulling back following Friday's strength.
Oncotarget Publishes New Data By Lantern Pharma, An AI Company Developing Cancer Therapies, Further Supporting Clinical Advancement Of LP-284, A Novel Synthetically Lethal Drug Candidate For Non-Hodgkin’s Lymphomas
Non-Hodgkin's lymphoma (NHL) is the seventh leading cause of cancer in the US, with 20-40% of patients experiencing relapsed or refractory disease with limited or no therapeutic options.
Publication
Here’s Why Humana (HUM) Stock Is Moving
Humana Inc (NYSE: HUM) shares are trading higher by 2.37% to $451.19 Wednesday morning. Shares of healthcare stocks are trading higher in sympathy with Elevance Health, which reported better-than-expected second-quarter financial results and raised guidance.